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Abstract
With advances in genetic testing and improved access to such advances, whole exome
sequencing is becoming a first-line investigation in clinical work-up of children with develop-
mental delay/intellectual disability (ID). As a result, the need to understand the importance
of genetic variants and its effect on the clinical phenotype is increasing. Here, we report on
the largest cohort of patients with HNRNPU variants. These 21 patients follow on from the
previous study published by Yates et al. in 2017 from our group predominantly identified
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from the Deciphering Developmental Disorders study that reported seven patients with
HNRNPU variants. All the probands reported here have a de novo loss-of-function variant.
These probands have craniofacial dysmorphic features, in the majority including widely spa-
ced teeth, microcephaly, high arched eyebrows, and palpebral fissure abnormalities. Many
of the patients in the group also have moderate to severe ID and seizures that tend to start
in early childhood. This series has allowed us to define a novel neurodevelopmental syn-
drome, with a likely mechanism of haploinsufficiency, and expand substantially on already
published literature on HNRNPU-related neurodevelopmental syndrome.
K E YWORD S
DDD study, exome sequencing, HNRNPU, intellectual disability, seizures
1 | INTRODUCTION
The clinical application of exome sequencing is becoming more impor-
tant in the treatment of undiagnosed rare genetic conditions (Need
et al., 2012). The cost of exome sequencing has decreased, the
processing speed has increased, and there has been an increase in
accuracy meaning that exome sequencing is becoming more common
as a molecular diagnostic test for those with a rare genetic disorder.
HNRNPU (OMIM *602869) is located on chromosome 1 between
bands q43 and q44. Pathogenic variants within this gene have been associ-
ated with several different phenotypes including Early Infantile Epileptic
Encephalopathy (EIEE), intellectual disability (ID), and craniofacial dys-
morphism (OMIM #617391: Epileptic encephalopathy; early infantile, 54). It
has been shown that HNRNPU is expressed in the adult brain, heart, kidney,
and liver with the highest expression in the cerebellum (Thierry et al., 2012).
Whole exome sequencing studies suggested haploinsufficiency as the main
mechanism of pathogenicity in HNRNPU, with loss-of-function variants pre-
dominantly reported in association with disease (Leduc et al., 2017).
In this study, we describe the clinical data of 21 probands with previ-
ously unreported, predicted pathogenic, de novo HNRNPU variants. These
HNRNPU variants were primarily identified through the Deciphering
Developmental Disorders (DDD) study and through personal contact with
clinicians following publication of the earlier series (Yates et al., 2017). We
then collated the information on the clinical phenotype and genotype,
which follows on from a previous study looking at seven individuals.
We have seen the reinforcement of previous findings such as a strong
link between HNRNPU and craniofacial dysmorphism, ID, speech and lan-
guage impairment, behavioral abnormalities, and seizures. We further found
data to support a possible link between HNRNPU and cardiac abnormalities.
2 | MATERIALS AND METHODS
2.1 | Editorial policies and ethical considerations
The DDD study has UK Research Ethics Committee approval
(10/H0305/83, granted by the Cambridge South REC, and GEN/284/12
granted by the Republic of Ireland REC).
2.2 | Methods
We identified 21 probands to be involved in this study. Although
more probands were identified with variants of uncertain clinical
significance and/or unknown inheritance, we narrowed down our
inclusion criteria to only include de novo variants that were classi-
fied as likely pathogenic or pathogenic (Class 4 or 5, respectively)
using the American College Medical Genetics (ACMG) variant clas-
sification system (Richards et al., 2015). Of the 21 probands identi-
fied in this study, 16 were identified through the DDD study via a
regional genetics center. The proband and their parents all under-
went trio whole exome sequencing where the HNRNPU variant was
identified. One proband was identified through clinical exome, and
the remaining four probands were identified by direct contact with
other clinicians.
A systematic method was used to perform an initial search for rel-
evant literature. The databases used include Web of Science,
MEDLINE via Ovid, PubMED, and The Cochrane Library. Searches
were undertaken using combinations of HNRNPU, clinical phenotype,
seizures, and ID. Publications were used based on their title, then the
abstract and further publications were identified through the refer-
ences of included papers using the snowball method. We only
included papers that used more than one proband.
We have presented our findings as percentages of the data avail-
able in this cohort.
3 | RESULTS
3.1 | Proband 1
Proband 1 was a female born to non-consanguineous parents with no
remarkable family history. The pregnancy was complicated by bleed-
ing in the third trimester. She was born at 41 weeks' gestation. She
had feeding difficulties as she was sleepy and floppy. Her birth weight
was 3.2 kg (33rd percentile). She had a moderate global developmen-
tal delay and absence seizures. She also had generalized neonatal
hypotonia. In view of her clinical phenotype, the differential diagnosis
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prior to recruitment to DDD included Prader–Willi syndrome and
myotonic dystrophy. Her magnetic resonance imaging (MRI) of the
brain was normal. The age of last evaluation was 0.67 years.
3.2 | Proband 2
Proband 2 was a male born to non-consanguineous parents with no
significant family history. The pregnancy was uncomplicated. He was
born at 28 weeks' gestation. He was an in-patient for 5 weeks after
birth, with no known feeding problems. His birth weight was 1.984 kg
(99th percentile). He sat independently at 6 months old, started
speaking at 13 months, and walked independently at 2–2.5 years old.
He suffered from seizures and had developmental regression, ID, and
behavioral concerns. His craniofacial dysmorphism included micro-
cephaly and sparse, thin eyebrows. His MRI brain imaging was
reported to be abnormal, but no further details were available. The
age of last evaluation was 11.32 years.
3.3 | Proband 3
Proband 3 was a male born to non-consanguineous parents with no
significant family history. The pregnancy was uncomplicated. He was
born at 40 weeks' gestation with no complications. He weighed
2.633 kg (third percentile). He had moderate global developmental
delay, hearing impairment and hirsutism. He had short stature, broad
thumbs, and cryptorchidism. He also suffered from seizures. He sat
independently at 10 months, spoke his first words at 18 months, and
walked at 20 months. The age of last evaluation was 16.24 years.
3.4 | Proband 4
Proband 4 was a male born to non-consanguineous parents with no
significant family history. The pregnancy was uncomplicated. He was
born at 40 weeks' gestation; he had feeding difficulties requiring
nasogastric tube (NGT) feeding. His birth weight was 2.492 kg (first
percentile). He had global developmental delay and generalized tonic-
clonic seizures. His craniofacial dysmorphism included a cupped ear,
brachycephaly, widely spaced teeth, bilateral ear pits, hooded eyelids,
and a frontal upsweep of hair. His delayed development and facial
features were reminiscent of Angelman syndrome. He sat indepen-
dently at 18 months, walked independently and spoke his first words
between 2.5–3 years. He had normal MRI brain imaging. The age of
last evaluation was 10.95 years.
3.5 | Proband 5
Proband 5 was a female born to non-consanguineous parents with no
significant family history. Her mother suffered from hypothyroidism.
Her father had widely spaced teeth. The pregnancy was complicated
by an abnormal scan. She was born at 32 weeks' gestation and was
admitted to Special Care Baby Unit (SCBU).
Her birth weight was 2.12 kg (92nd percentile). She had global
developmental delay. She walked independently at 2.5–3 years and
her first words were at 5 years old. She had short stature accompa-
nied with childhood-onset truncal obesity. Her craniofacial dys-
morphism included delayed eruption of permanent teeth, widely
spaced teeth, a high-arched palate, and cleft lip and palate. She suf-
fered from seizures. She had normal MRI brain imaging. The age of
last evaluation was 12.58 years.
3.6 | Proband 6
Proband 6 was a female born to non-consanguineous parents with no
significant family history. The pregnancy was uncomplicated, and she
was born at 41 weeks' gestation. Her birth weight was 4.02 kg (90th
percentile). She had moderate global developmental delay and a possi-
ble impairment of speech. She sat independently at 9 months. She
walked independently at 2–2.5 years. Her first words were between
the ages of 2.5–3 years. At the age of 6, she was able to speak two-
to three-word sentences. She had moderate to severe ID. She also
suffered from behavioral disorders including sensory issues, self-harm,
and aggression toward family members, destructive to toys, and had
no sense of danger. She had bilateral postaxial hand polydactyly, right
foot polydactyly, and muscular hypotonia. She was also wheelchair-
bound due to marked ligamentous laxity and obesity. She suffered
from absence seizures with an atonic element, which started at the
age of 10 months. Her tonic-clonic seizures are currently under
control.
Her MRI brain imaging showed stable symmetrical white mat-
ter signal abnormalities throughout the brain; however, this pre-
dominantly affected the periventricular regions of both the parietal
lobes and frontal lobes. There were also stable simple cysts adja-
cent to the temporal horn of the right lateral ventricle in the region
of the hippocampus (Figure 1). The age of last evaluation was
2.77 years.
3.7 | Proband 7
Proband 7 was a female born to non-consanguineous parents with no
significant family history. Ventriculomegaly was detected at the
20-week scan. She was born at 35 weeks' gestation and was admitted
to SCBU for 14 days. She was fed through an NGT and discharged on
a bottle. Her birth weight was 2.2 kg (33rd percentile). Her craniofa-
cial dysmorphism included nystagmus and strabismus. She also suf-
fered from central hypoventilation, recurrent hand flapping, central
hypotonia, and fatigable weakness. In view of her weakness and hypo-
tonia, she was investigated for congenital myasthenic syndrome prior
to recruitment to the DDD study. She sat independently and spoke
her first words between 2 and 2.5 years. She had normal MRI brain
imaging. The age of last evaluation was 2.58 years.
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3.8 | Proband 8
Proband 8 was a female born to non-consanguineous parents with no
significant family history. The pregnancy was complicated by intra-
uterine growth retardation. She was born at 39 weeks' gestation. Her
birth weight was 2.66 kg (10th percentile). She had global
developmental delay. She first socially smiled at 6 weeks and sat inde-
pendently at 12 months. Her craniofacial dysmorphism consisted of a
prominent median palatal raphe. She was born with congenital cardiac
abnormalities, namely atrial septal defect (ASD) and a patent ductus
arteriosus (PDA). She suffered from seizures. Her MRI brain imaging
was abnormal with enlargement of the frontal horns of the lateral
F IGURE 1 (a) Patient 6:
MRI brain imaging (aged
16 months) showed stable
symmetrical white matter signal
abnormalities throughout the
brain; however, this
predominantly affected the
periventricular regions of both
parietal lobes and frontal lobes.
There were also stable simple
cysts adjacent to the temporal
horn of the right lateral
ventricle in the region of the
hippocampus (shown in arrow).
(b) Patient 8: MRI brain imaging
was abnormal with
enlargement of the frontal
horns of the lateral ventricles
and some delayed myelination.
(c) Patient 19: MRI brain
imaging (aged 13 months)
showed periventricular
leukomalacia with no other
abnormalities. MRI, magnetic
resonance imaging
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ventricles and some delayed myelination (Figure 1). The age of last
evaluation was 4.09 years.
3.9 | Proband 9
Proband 9 was a female born to non-consanguineous parents. There
were no complications in the pregnancy, and she was born at
41 weeks' gestation. She was admitted to SCBU for 1 day but had no
feeding problems. Her birth weight was 2.68 kg (fifth percentile). She
had a global development delay including delayed speech and lan-
guage. She sat independently at 6 months, walked independently at
2–2.5 years, and her first words were at 3–4 years. Her craniofacial
dysmorphism consisted of brachycephaly, long eyelashes, long phil-
trum, low anterior hairline, microcephaly, and up-slanted palpebral fis-
sures. She suffered from generalized tonic-clonic seizures. Due to her
facial features, she was considered to clinically have Cornelia de Lange
syndrome prior to recruitment to DDD study. Her MRI brain imaging
was normal. The age of last evaluation was 15.85 years.
3.10 | Proband 10
Proband 10 was a female born to non-consanguineous parents with
two affected siblings, raising the possibility of gonadal mosaicism in
one of the parents. Her mother had a bleed in her third trimester of
pregnancy. The proband was born at 39 weeks' gestation with no
complications. Her birth weight was 2.655 kg (10th percentile) and
her head circumference was 34 cm (51st percentile). She had develop-
mental regression and profound ID. Her first social smile was at
9 weeks and she sat independently at 12 months. She could speak
single words at 2 years old; however, she regressed to no speech. At
the age of 3–4 years, she was able to “cruise” around furniture. How-
ever, she had regressed and now lost this skill. Her craniofacial dys-
morphism included progressive microcephaly, synophrys, widely
spaced teeth, and bruxism. She had functional respiratory abnormality.
She suffered from focal seizures with generalization as well as epi-
sodes of nonconvulsive status. She had episodes of clustering focal
seizures resistant to standard antiepileptic medications. Her MRI brain
imaging was abnormal with simplified gyral patterns, reduced white
matter volume, and a slender corpus callosum. The age of last evalua-
tion was 11.75 years.
3.11 | Proband 11
Proband 11 was a female born to non-consanguineous parents with
no significant family history. Assisted reproduction (intracytoplasmic
sperm injection) was used in conception. The pregnancy was compli-
cated by decreased fetal movements toward the end of pregnancy.
She was born at 40 weeks' gestation but spent 7 days in SCBU requir-
ing NGT feeding because of feeding difficulties. Her birth weight was
3.54 kg (62nd percentile). At the age of 15 years, her head
circumference was 53.4 cm (ninth percentile). She exhibited some ste-
reotypical hand movements and bruxism. She was not notably dys-
morphic but had slender hands and feet, a high palate, and misaligned
upper incisors.
She had severe global developmental delay, crawling at
16 months and walking independently at 2.5 years. Her first words
were at 12 months but despite initially learning several words and
starting to put two words together, these were subsequently lost after
the age of 2 years along with the ability to sign. However, this was
followed by slow and gradual progress and aged 15 years, she now
has a vocabulary of around 15 words, but their pronunciation is indis-
tinct. She can use a tablet computer to find and view photographs and
communicate using this device. She can mobilize short distances but
has a wide and stiff gait. She was toilet-trained by day and was gener-
ally dry at night. Her behavior can be affectionate but also stubborn at
times. Her differential diagnosis prior to recruitment to DDD study
included Angelman syndrome, Rett syndrome, and Smith Magenis
syndrome in view of her facial dysmorphism, seizure history, and
developmental regression.
At 9 months, she had a febrile convulsion. Another seizure
occurred aged 2 years, and thereafter, she developed more frequent
seizures including absences and tonic-clonic fits. After a trial of carba-
mazepine and sodium valproate with little effect, her seizures were
controlled with topiramate and levetiracetam. As a teenager, she is
currently only on levetiracetam. Her MRI brain imaging was normal.
The age of last evaluation was 9.99 years.
3.12 | Proband 12
Proband 12 was a male born to non-consanguineous parents with no
significant family history. There were no complications in pregnancy,
and he was born at 40 weeks' gestation with a birth weight of 3.18 kg
(22nd percentile). He had a cognitive impairment and autism. He had
speech therapy at school and went to a special needs school. His cra-
niofacial dysmorphism included prominent, heavy, wide arched eye-
brows, a triangular shaped face, and flat cheekbones. He suffered
from two seizures in his lifetime. His phenotype was reminiscent of
Cornelia de Lange syndrome particularly his wide arched eyebrows
and facial dysmorphism prior to recruitment to DDD study. The age
of last evaluation was 16.68 years.
3.13 | Proband 13
Proband 13 was a female born to non-consanguineous parents with
no significant family history. There were no complications of preg-
nancy. She was born at 37 weeks' gestation and admitted to the
SCBU for 2 days. Her birth weight was 2.855 kg (56th percentile). She
had a severe global developmental delay and stereotypy. She sat inde-
pendently at 15 months and walked independently at 2.5–3 years.
Her craniofacial dysmorphism included strabismus, drooling, promi-
nent nasal bridge, and a wide nasal bridge. She had a short fourth and
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fifth metacarpal and tapered finger. Her gait was broad-based. She
suffered from seizures. Her seizures (tonic/tonic-clonic) started at the
age of 12 months. These improved with sodium valproate and
lamotrigine, but she continued to have frequent drop attacks. Episodic
hyperventilation started in the first 2 years of life and a computerized
tomography (CT) of brain at 2.5 years of age showed minor frontal
atrophy. She has never had any further imaging of the brain. One of
the most striking clinical features was her episodic hyperventilation
followed by quite prolonged apnoeas where she became cyanotic.
She also had hand-wringing and bruxism. In view of the hand-wring-
ing, hyperventilation, seizures, and strabismus, her differential diagno-
sis prior to recruitment to DDD study was Rett syndrome and Pitt-
Hopkins syndrome. The age of last evaluation was 17.63 years.
3.14 | Proband 14
Proband 14 was a male born to non-consanguineous parents with no
significant family history. He was born at 40 weeks’ gestation follow-
ing an uncomplicated pregnancy. He was a breech delivery and
required 1 day at the SCBU but did not have any feeding problems.
His birth weight was 2.86 kg (ninth percentile). He had a slender build,
with a weight and height at −2 SD. He had a global developmental
delay with a total intelligence quotient of 52. He also had delayed
speech and language skills. He walked independently and spoke his
first words at 2 years old. His craniofacial dysmorphism included doli-
chocephaly, prominent forehead, down-slanting palpebral fissures,
slightly low hanging columella, and a thin upper lip as well as long fin-
gers and toes. His initial febrile seizures started at the age of 7 years,
which progressed to focal seizures that were well controlled with
sodium valproate. His MRI brain imaging was normal. The age of last
evaluation was 13 years.
3.15 | Proband 15
Proband 15 was a male born to non-consanguineous parents with no
significant family history. At 5 months' gestation, his mother fell onto
her abdomen. At the antenatal screening, there was a 1 in 24 risk of
Down syndrome, but the amniocentesis was normal. There was an
abnormal 20-week scan showing mild tricuspid regurgitation. He was
born at 39 weeks in a good condition with a birth weight of 3.2 kg
(91st percentile).
Developmentally, he sat independently for the first time aged
12 months, walked independently aged 2 years, and his first words
were at the age of 2.5 years. He spoke in single words at the age of
5 and did not understand simple instructions. He had a global devel-
opmental delay with moderate motor delay and severe speech and
language delay. He had a moderate ID, meaning he was in a special
unit in a mainstream school and received one-to-one help. He had
some aggressive outbursts and had no sense of danger. His craniofa-
cial dysmorphism included left-sided plagiocephaly, torticollis, low-set
ears, prominent forehead, epicanthic folds, prominent nasal tip, and
sparse hair. He also suffered from trivial tricuspid regurgitation. His
gait was unsteady, and he had frequent falls.
He suffered from seizures that began at the age of 13 months.
He had his last seizure at 4 years old and he is currently not on any
anticonvulsant medication. He initially presented with typical febrile
convulsions, later some became afebrile episodes and vacant spells.
He suffered from intermittent left extropia and mild hypermetropia.
He also had low muscle tone, particularly core tone. His phenotype
was reminiscent of Angelman syndrome. His MRI brain imaging was
normal. The age of last evaluation was 5.7 years.
3.16 | Proband 16
Proband 16 was a 20-year-old female referred to the 100,000
genomes project with severe ID and epilepsy. She was born post-term
with fetal distress at delivery. She weighed 3.7 kg (75th–91st centile)
at birth.
She had always been obese with hyperphagia. At 20 years of
age, she had severe ID with absent speech and nonmobile. Her cra-
niofacial dysmorphism included dysplastic earlobes, short palpebral
fissures, broad nasal bridge, hypoplastic alae nasi, tented upper lip,
and a prominent jaw. She had small hands and feet with tapering
fingers, bilateral single palmar creases, and short fifth fingers. She
suffered from postnatal microcephaly and her first seizure was at
6 months. She suffered with epileptic encephalopathy since the
age of 2, when spasticity became evident subsequently. Her epi-
lepsy was controlled with sodium valproate. She has Rett-like fea-
tures including bruxism. Her MRI brain imaging was normal. There
were three healthy siblings born subsequently. The age of last eval-
uation is 20 years of age.
3.17 | Proband 17
Proband 17 was a 12-year-old girl, the second child born to non-
consanguineous parents who experienced two early spontaneous mis-
carriages. They had a healthy son 18 months older than the proband.
The mother was taking fluoxetine at the time of this unplanned con-
ception, but the pregnancy was otherwise uncomplicated. She had a
normal delivery at 39 weeks' gestation with a birth weight of 3.175 kg
(50th centile). She initially had a low temperature and did not feed
well. There were concerns about poor eye contact at 5 weeks and she
suffered a varicella infection at 8 weeks. She demonstrated growth
delay and global developmental delay. At 3 years, she could stand
with support and crawl, had babble but no speech, and could not feed
herself. She manifested hand-wringing movements, prompting testing
for Rett syndrome which was negative. She sat and walked indepen-
dently at 3 years and 5–8 years, respectively. Currently, she has
severe ID with no speech, her only word being “hi-ya” and she was
not toilet trained. She was generally content, capable of tantrums,
could use a tablet computer, and followed some instructions slowly.
She slept poorly.
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Aged 14 months, she developed a seizure disorder that was sub-
sequently well controlled on sodium valproate and lamotrigine. Her
last generalized tonic-clonic seizure occurred at 2 years though
absences continue infrequently. Her craniofacial dysmorphism con-
sisted of mild synophrys and a short nose, and she has short finger
and toes with fifth finger clinodactyly. She wears glasses for alternat-
ing divergent strabismus. Her MRI brain imaging was normal. The age
of last evaluation was 12 years of age.
3.18 | Proband 18
Proband 18 was a male born to non-consanguineous parents with no
significant family history. He was born at 36 weeks' gestation and had
difficulties in establishing breast feeding. His birth weight was
2.155 kg (eighth centile). He had a severe developmental delay and a
regression of language; he was only able to say “mummy” but was able
to say two to three sentences previously. He smiled socially for the
first time aged 8 weeks, sat independently aged 14 months, and wal-
ked independently at the age of 2–2.5 years.
His craniofacial dysmorphism included coarse facial features,
epicanthus, high arched eyebrow, long palpebral fissure,
trigonocephaly, widely spaced teeth, and a wide mouth. He also had
prominent fingertip pads and a broad thumb. He also suffered from
tonic-clonic seizures, atypical absences, recurrent absence status,
probable atonic seizures with later emergence of tonic seizures, and
gelastic seizures. Despite being on lacosamide, sodium valproate, and
phenytoin, he was still having several seizures a day. He was reported
to have a fluctuating pattern of functional ability. When he had pro-
longed periods of seizures and nonconvulsive status, his functional
mobility, awareness and communication, general well-being including
appetite and sleep, could be severely disrupted. He had a pattern of
being chronically fatigued and very slow to get up in the morning. He
also had difficulties with motor initiation.
He was commenced on a nicotine patch trial to reduce the num-
ber of seizures. Due to the severity of his seizures, he had been put
into an induced coma and been intubated for a long period. He had an
abnormal MRI that noted unusual areas of altered signal intensity
within the corpus callosum; however, this had resolved 3 years later
on repeat imaging. The age of last evaluation was 13.9 years.
3.19 | Proband 19
Proband 19 was a female proband born to non-consanguineous par-
ents with no significant family history. During pregnancy, the mother
suffered with maternal pre-eclampsia; however, there was normal
maternal serology and normal antenatal scans. The proband was born
at 28 + 5 weeks' gestation by emergency cesarean section. She was
born in good condition with an appearance, pulse, grimace, activity,
and respiration (APGAR) score of 9 at both 1 and 5 min of age. She
was admitted to the SCBU for 45 days where she was treated conser-
vatively for presumed necrotizing enterocolitis. Her birth weight was
0.865 kg (ninth centile) and her head circumference at birth was
23.7 cm (second centile).
She had generally delayed development; she did not walk until
the age of 2 years and did not speak until 3.5 years. She has never
spoken in sentences. She was also noted to have autistic traits in the
form of frequent hand wringing and delay in social communication,
which initially raised the suspicion for Rett syndrome before further
studies were undertaken. She had problems with bilateral adhesive
otitis media, which required grommet insertion. She also had early
onset exotropia that entailed wearing glasses early in her life. She has
never been successfully toilet-trained and has always suffered with
constipation. Her craniofacial dysmorphism included broad forehead
and small chin with a degree of lumbar lordosis. Hand stereotypies
were also observed.
Her seizures started at 10 months of age that were initially febrile
seizures, followed by prolonged afebrile episodes. After a period of
reasonable control of seizures on sodium valproate, she started having
seizures again at the age of 5 years and continued to have different
types of seizures: absence, myoclonic, and episodes of nonconvulsive
status epilepticus that required prolonged hospital admissions and
was confirmed by electroencephalogram. They were resistant to mul-
tiple antiepileptic medications. Temporary improvement with keto-
genic diet had been observed, but this was not tolerated for more
than a few months on each occasion because of gastrointestinal side
effects. Her MRI brain imaging (aged 13 months) showed per-
iventricular leukomalacia with no other abnormalities (Figure 1c). The
age of last evaluation was 8.5 years.
3.20 | Proband 20
Proband 20 was a female born to non-consanguineous parents with
no remarkable family history. There were abnormal scans during preg-
nancy where the proband appeared small for their dates. She was
born at 40 + 9 weeks' gestation and was admitted to SCBU due to
transient tachypnoea of the new-born for a brief period. Her birth
weight was 2.68 kg (second–ninth centile). She has moderate to
severe developmental delay. She does speak but is very delayed with
sentences only developing over the past 5 years. She has no formal
behavioral disorder diagnosed but can be difficult, for example,
screaming when unhappy.
Craniofacial dysmorphism included up-slanted palpebral fis-
sures, long eyelashes, and a thin upper lip. Other aspects of her
phenotype to note are her broad thumbs, scoliosis, ASD that closed
early in life, pes planus, cold feet, and digestive problems that
include bringing up a lot of phlegm. When she was younger, the
proband's phenotype was clinically thought to be Cornelia de Lange
syndrome.
She suffered from seizures at 16 months but is currently seizure
free on medication. She had an encephalopathic illness at around
16 months. She sat independently at 2 years and spoke one word at
this time. Her MRI brain imaging was normal. The age of last evalua-
tion was 23 years.
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3.21 | Proband 21
Proband 21 was a male born to non-consanguineous parents. Prior
to this pregnancy, there were three miscarriages. There were no
complications of pregnancy. He was born at 40 + 2 weeks and
weighed 2.46 kg (second centile). He had global developmental
delay, which included many single words aged 5. He was formally
diagnosed with autism spectrum disorder at the age of five. His cra-
niofacial dysmorphism included frontal bossing, prominent metopic
suture, hypertelorism, long eyelashes, long smooth philtrum, sparse
eyebrows medially, down-turned corners of the mouth, flattened
nasal bridge, and a short nose. Other aspects of the phenotype to
note are bilateral postaxial polydactyly, orchidopexy for unde-
scended testes, hypotonia, joint laxity, and hypothyroidism, which
is currently well treated with thyroxine. Relevant family history
included the mother suffering from hypothyroidism that is also
treated with thyroxine.
This proband also suffered from seizures from the age of
16 months with initial febrile seizures and is currently treated with
levetiracetam. There is no epileptic encephalopathy present. He sat
independently at 16 months, walked independently at 3 years, and he
spoke three words at 14 months. He is the only affected member of
TABLE 1 Sequencing results
Patient HNRNPU variant Predicted protein change ACMG criteria Classification
1 c.619C>T p.(GIn207*) PVS1, PM2-M, PS2-S Pathogenic
2 c.1925_1926del p.(Leu642Profs*5) PVS1, PM2-M, PS2-S Pathogenic
3 c.1450C>T p.(Arg484*) PVS1, PM2-M, PS2-S Pathogenic
4 c.395_401del p.(Asn132Thrfs*63) PVS1, PM2-M, PS2-S Pathogenic
5 c.2083_2084del p.(Ser695Trpfs*6) PVS1, PM2-M, PS2-S Pathogenic
6 c.1836del p.(Tyr613Ilefs*11) PVS1, PM2-M, PS2-S Pathogenic
7 c.67C>T p.(Arg23*) PVS1, PM2-M, PS2-S Pathogenic
8 c.692-1G>A p.? (splice site variant) PVS1, PM2-M, PS2-S, PP3-P Pathogenic
9 c.706_707del p.(Glu236Thrfs*6) PVS1, PS2-S, BS2-S Pathogenic
10 c.1088G>A p.(Trp363*) PVS1, PM2-M, PS2-S Pathogenic
11 c.1743+1G> C p.? (splice site variant) PVS1, PM2-M, PS2-S, PP3-P Pathogenic
12 c.1801C>T p.(Arg601*) PVS1, PM2-M, PS2-S Pathogenic
13 c.847_857del p.(Phe283Serfs*5) PVS1, PS2-S, BS2-S Pathogenic
14 c.837_839del p.(Glu279del) PS2-S, PM2-M, PM4-M Likely pathogenic
15 c.2167+35_*4156del p.? (deletion of last three exons) PVS1-S, PS2-S, PM2-M Pathogenic
16 c.1089G>A p.(Trp363*) PVS1, PM2-M, PS2-S Pathogenic
17 c.1641del p.(Asp548Ilefs*5) PVS1, PM2-M, PS2-S Pathogenic
18 c.1681del p.(Gln561Serfs*45) PVS1, PM2-M, PS2-S Pathogenic
19 c.454_466del p.(Ala152Thrfs*41) PVS1, PM2-M, PS2-S Pathogenic
20 c.706_707del p.(Glu236Thrfs*6) PVS1, PM2-M, PS2-S Pathogenic
21 c.712_715del p.(Lys238AlafsTer100) PVS1, PM2-M, PS2-S Pathogenic
PVS1 Null variant (nonsense, frameshift, canonical ±1 or 2 splice sites, initiation codon, single, or multiexon deletion) in a gene where LOF is a known
mechanism of disease
PS2 de novo (both maternity and paternity confirmed) in a patient with the disease and no family history
PM2 Absent from controls (or at extremely low frequency if recessive) in the Genome Aggregation Database (gnomAD)
PM4 Protein length changes as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants
PP3 Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact,
and so on)
BS2 Observed in a healthy adult individual for a dominant with full penetrance expected at an early age
-S Strong level evidence
-M Moderate level evidence
-P Supporting level evidence
Note: HNRNPU variant identified in this study alongside the predicted protein change, ACMG variant classification criteria and final classification. Variant
nomenclature using gene transcript NM_031844.2 (GRCh37). Population data were checked using gnomAD v2.1.1 (controls) data set, which can be
accessed through https://gnomad.broadinstitute.org. PVS1 weight was determined using guidelines in Abou Tayoun et al., 2018. PS2 weight used at a
strong level since de novo status was confirmed in all cases.
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the family. His MRI brain imaging was reported normal. The age of last
evaluation was 5 years.
3.22 | Sequencing results
Table 1 provides a list of pathogenic/likely pathogenic variants in the
21 probands reported here. The table also provides ACMG criteria for
classification of variant pathogenicity. Variant nomenclature is
according to gene transcript NM_031844.2 (GRCh37). Figure 2 shows
details of all the variants so far reported in HNRNPU including variants
identified in this study. Tables 4 and 5 provide a list of all the variants
so far published in HNRNPU to compare with Table 1.
4 | DISCUSSION
4.1 | Gene function
The HNRNPU gene encodes for HNRNPU (Heterogeneous nuclear
ribonucleoprotein U) and has been linked to several different func-
tions including X-inactivation, genomic stability, telomere-length regu-
lation and nuclear chromatin, and transcription organization.
The role of HNRNPU in X-inactivation involves a long piece of
noncoding RNA called Xist, which is central to this process. It has
been found that HNRNPU protein is required for Xist RNA association
with the X chromosome and thereafter inactivation. Embryonic stem
cell research has shown that cells that do not express HNRNPU were
unable to form an inactive X chromosome, resulting in biallelic expres-
sion of X-linked genes (Hasegawa et al., 2010). HNRNPU is the
protein that allows the Xist RNA to coat the inactive X chromosome
(Xi) through its DNA as well as its RNA binding (Hasegawa
et al., 2010). HNRNPU is made up of three conserved domains: scaf-
fold attachment factor (SAF), SPRY, and RGG. The SAF domain over-
sees the scaffold matrix, the SPRY domain is a Spla and ryanodine
receptor with no known function, and RGG is an RNA-binding domain
made up of RGG repeats. The RGG site is important as it mediates
attachment to the Xist RNA while HNRNPU interacts directly with
the Xist via the RNA-binding domain.
HNRNPU has been found to code for a family of proteins that are
able to bind nucleic acids and heterogeneous nuclear RNA (HnRNA).
HnRNA can bind to DNA and RNA, and it binds a scaffold attachment
region (SAR) to the DNA, indicating where the nuclear matrix should
attach. Therefore, this suggests that it plays a role in regulating inter-
phase via caRNA, which is a chromatin-associated RNA, and resulting
in the stability of the genome (Nozawa et al., 2017).
There is also evidence to suggest that HNRNPU is also important
as an RNA polymerase (Pol II) elongation inhibitor, consequently
preventing RNA Pol II-mediated transcription (Bi et al., 2013).
4.2 | HNRNPU-related syndrome
From the data that we have collected, there are some common pat-
terns in the phenotypic expression of the individuals. These include
95% of the probands that have craniofacial dysmorphism, the most
common including palpebral fissure abnormalities (24%), microcephaly
(19%), and wide spaced teeth (19%). Of the 21 probands, 20 of these
have seizures recorded. Of these seizures, 25% have absence seizures
and 25% have generalized tonic-clonic seizures.
F IGURE 2 Variant interpretation plot for all probands with pathogenic HNRNPU variants in this cohort and published literature [Color figure
can be viewed at wileyonlinelibrary.com]
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Another key feature is developmental delay—95% of the pro-
bands are recorded as having developmental delay. Of these, 66% also
have delayed speech and language skills. In addition to this, 50% also
have a degree of ID and 50% have a behavioral disorder from the data
recorded. On closer analyses of the phenotypes, they were found to
be similar to Cornelia de Lange, Angelman, Rett and Pitt Hopkins syn-
dromes, all of which have specific craniofacial dysmorphism, ID, and
behavioral phenotype present showing that this could be part of the
HNRNPU-related phenotype differential diagnoses. However, most of
the craniofacial dysmorphism that were recorded were unique to the
proband. Less commonly observed phenotypes included postaxial
polydactyly, PDA, and an atrial septal defect (two probands). Three
patients presented with respiratory concerns: breath holding, func-
tional respiratory abnormality, and central hypoventilation.
The main differential diagnosis for HNRNPU-related syndrome from
our cohort was Rett syndrome with 19% probands noted as having Rett-
like phenotypic expressions. The most common reasons for suspecting
Rett syndrome were hand wringing, bruxism, delay in social interaction,
and hyperventilation. This was followed by Angelman syndrome with
14% probands found to have phenotype similar to this. Angelman syn-
drome was considered as a differential diagnosis' due to developmental
delay, facial features, and an affectionate character. Three probands also
had phenotypes similar to Cornelia de Lange with Prader–Willi, myotonic
dystrophy, congenital myasthenic syndrome, Fragile X, Smith Magenis
syndrome, and Pitt-Hopkins phenotypes, all described as differential
diagnoses for patients with HNRNPU-related syndrome.
Table 2 describes the phenotype of the cohort reported here with
clustering of clinical features wherever applicable. Tables 6 and 7 have
all the detailed phenotypic info: Table 6 for probands 1–11 and
Table 7 for probands 12–21. The data that we have unearthed adds
to the growing body of data on HNRNPU showing a particularly strong
link between HNRNPU and seizures and craniofacial dysmorphisms
that we have described in greater detail than previous studies as well
as finding possible link to cardiac abnormalities.
4.3 | Literature review
A comprehensive review of the literature published so far on
HNRNPU-related neurodevelopmental syndrome shows data from a
further six papers that have reported on clinical features (Table 3) with
individuals shown to have variants in HNRNPU (see Supporting Infor-
mation). Four of the HNRNPU cohorts reported showed that all pro-
bands that were included had craniofacial dysmorphism while one did
not report data on this, and the remaining paper showed 86% pro-
bands having craniofacial dysmorphism. In our cohort, the most com-
monly observed dysmorphism included widely spaced teeth (19%),
microcephaly (19%), and palpebral fissure abnormalities (24%).
All of the previously published studies showed ID in all probands.
This is different to our findings, however we included all patients from
our cohort and not just those that were assessed due to the data that
we have available. Interestingly, however, 95% of our probands had
developmental delay. Out of the total 59 probands from all the papers
combined, 46 (78%) had a speech and language impairment. This var-
ied between non-verbal to short sentences. The behavioral abnormali-
ties reported tended to show autistic tendencies, aggressive
tendencies, or being very happy and social. Of the total number of
probands reported of having a behavioral abnormality, 43% had
autism or autistic tendencies, 21% had aggressive behavior, and 11%
were very social and happy. The less common behavioral phenotypes
included obsessive–compulsive disorder and self-stimulatory
behavior.
Of the 61 probands with data on seizures, 56 (92%) of these had
seizures. In our study, the most common form of seizure was
TABLE 2 The more common phenotypes
Total (%)
Developmental delay 95
Developmental regression 10
Moderate 15
Moderate to severe 5
Severe 30
Present 35
Data not available 5
Degree of intellectual disability 52
ID present but severity not known 55
Moderate 18
Moderate to severe 9
Severe 18
Data not available 48
Craniofacial dysmorphism 95
Microcephaly 20
Abnormal head shape 25
Prominent forehead 15
High arched, thin eyebrows 15
Palpebral fissure abnormalities 25
Epicanthus 10
Abnormalities of ear 25
Abnormalities of hair 15
Synophrys 10
Wide spaced teeth 20
Delayed eruption/maligned upper incisors 10
Bruxism 15
High palate 10
Hypermetropia 10
Data not available 5
Seizures 95
Absence 25
Generalized tonic–clonic 25
Focal 10
Unknown 35
Data not available 5
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generalized tonic-clonic seizures 24% and absence seizures 24%.
Depienne et al., 2017 showed that 57% had generalized tonic-clonic
and 57% had absence seizures, of these 43% of these probands had
generalized tonic-clonic and absence seizures.
Thirty-five probands were reported as having a brain abnormality
on imaging. The most common abnormalities seen were a thin corpus
callosum 14%, wide ventricles 5/35 14%, delayed myelination 14%,
generalized atrophy 9%, and cerebellar vermis atrophy 6%. From the
MRI imaging in our cohort and review of previously published litera-
ture, there does not appear to be uniform findings on brain imaging
that would help point toward this diagnosis and a normal MRI brain
scan would not preclude this as a diagnosis.
Ten probands were recorded as having a cardiac abnormality,
these included ASD 50%, PDA 13% transposition of the great vessels
13%, tricuspid atresia 13%, VSD 25%, and pentalogy of Fallot 13%
and aortic dilation 13%. Five probands have recorded data on renal
abnormalities, these include agenesis of the kidney 60%, unilateral
multicystic kidney 20%, and renal pelvic ectasia 20%.
In our cohort, 24% patients were born prematurely (less than
37 weeks). However, when compared with the literature on
HNRNPU-related disorder, Leduc et al. (2017) and Bramswig
et al. (2017) found that 25% and 14% in their series, respectively,
were premature, while Caliebe et al. (2010) and Yates et al. (2017) had
no premature births in their cohort. The remaining papers did not
record this information. Therefore, it does not appear that prematurity
is a consistent feature with HNRNPU-related disorder.
As is demonstrated in the variant plot (Figure 2), all the patho-
genic variants reported in HNRNPU appear to be loss-of-function vari-
ants and almost all of them were de novo. There were very few
missense variants reported in the literature so far and this gene has an
overall borderline constraint to missense changes (constraint score of
z = 3.37; z ≥ 3 predicts gene intolerance to missense variants)
(Havrilla, Layer, & Quinlan, 2019). The region with the lowest ratio of
observed to expected missense variants using the gnomAD data is
mapped to amino acids p.521 to p.640. However, with the limited
numbers of identified missense/in-frame deletion/insertion variants in
TABLE 4 Variants published in the HNRNPU by cDNA order,
nomenclature using gene transcript NM_031844.2 (GRCh37)
cDNA number Protein number Published paper
c.16delinsATT p.(Val6Ilefs*4) Depienne et al. (2017)
c.23del p.(Val8Glufs*4) Yates et al. (2017)
c.418G>A p.(Glu140Lys) Yates et al. (2017)
c.511C>T p.(Gln171*) Bramswig et al. (2017)
c.523C>T p.(Gln175*) Bramswig et al. (2017)
c.651_660del p.(Gly218Alafs*118) Leduc et al. (2017)
c.692-1G>A p.? Depienne et al., 2017
c.817C>T p.(Gln273*) Bramswig et al. (2017)
c.960G>A p.(Trp320*) Yates et al. (2017)
c.970A>G p.(Arg324Gly) Bramswig et al. (2017)
c.1089G>A p.(Trp363*) Leduc et al. (2017)
c.1117+1G>A p.? Yates et al. (2017)
c.1132T>C p.(Ser378Pro) Bramswig et al. (2017)
c.1424_1425insTC p.(Ile476Profs*7) Yates et al. (2017)
c.1628dup p.(Lys544Glufs*25) Yates et al. (2017)
c.1664del p.(Leu555Argfs*51) Yates et al. (2017)
c.1681C>T p.(Gln561*) Depienne et al., 2017
c.1681del p.(Gln561Serfs*45) Depienne et al., 2017
c.1714C>T p.(Arg572*) Leduc et al. (2017)
c.1744_1767del p.(Thr582_Gln589del) Bramswig et al. (2017)
c.1868dup p.(Glu624Argfs*24) Depienne et al., 2017
c.2270_2271del p.(Pro757Argfs*7) Leduc et al. (2017)
c.2299_2302delAACA p.(Asn767Glufs*66) Depienne et al., 2017
c.2425-3C>A p.? Depienne et al., 2017
TABLE 3 Clinical features of patients with HNRNPU variants
This study
Yates
et al. (2017)
Bramswig
et al., 2017
Depienne
et al., 2017
Thierry
et al., 2012
Caliebe
et al. (2010)
Leduc
et al., 2017
Craniofacial dysmorphism (%) 95 86 100 n/a 100 100 100
Intellectual disability (%) 52 100 100 100 100 n/r 100
Speech and language impairment (%) 67 86 100 100 50 100 100
Behavioral abnormality (%) 52 71 57 n/r 44 50 50
Seizures (%) 95 71 86 86 100 100 100
MR brain abnormality (%) 48 29 71 60 73 100 75
Cardiac abnormality (%) 14 14 67 n/r n/r 50 n/r
Renal abnormality (%) 0 0 75 n/r 100 25 n/r
Note: n/r indicates not recorded.
TABLE 5 Copy number variants published in HNRNPU
Gene aberration Published paper
Whole gene deletion (1 patient) Thierry et al. (2012)
Whole gene deletion (1 patient) Caliebe et al. (2010)
Intragenic duplication of
exons 1–3 (1 patient)
Bramswig et al. (2017)
Note: Please note that whole gene deletions were part of a larger deleted
region included other adjacent genes.
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TABLE 6 Phenotypic data patients 1–11
Patient number 1 2 3 4 5 6 7 8 9 10 11
ID DDD-290747 DDD-264725 DDD-305034 DDD-266412 DDD-279866 DDD-307385 DDD-305434 DDD-268181 DDD-279875 DDD-259668 DDD-266124
Genotype c.619C>T c.1925_1926del C.1450C>T c.395_401del c.2083_2084del c.1836del c.67C>T c.692-1G>A c.706_707del c.1088G>A c.1743+1G>C
Protein change p.Gln207Ter p.
Leu642ProfsTer5
p.Arg484Ter p.
Asnl32ThrfsTer63
p.
Ser695TrpfsTer6
p.
Tyr613llefsTer11
p.Arg23Ter splice_acceptor_variant p.
Glu236ThrfsTer6
p.Trp363Ter splice_donor_variant
Heterozygous Het Het Het Het Het Het Het Het Het Het Het
Gender F M M M F F F F F F F
Developmental
delay
Moderate,
global
Regression Moderate,
global
Global Global Moderate, global n/a Global developmental
delay
Global Regression,
stereotypy
Severe, abnormality
of movement
Speech
impairment
n/a n/a n/a n/a n/a Possibly n/a n/a Delayed Absent speech Lost ability to speak
but now has 15
words
Degree of ID n/a ID present, degree
unknown
n/a n/a n/a Moderate to severe n/a n/a n/a Profound Severe
Behavior n/a Abnormal n/a n/a n/a Sensory issues,
self-harm,
aggressive toward
family members,
destructive to
toys, no sense of
danger
n/a n/a n/a n/a Can be affectionate
but stubborn
Stature n/a n/a Short n/a Short n/a n/a n/a n/a n/a n/a
Craniofacial
dysmorphism
n/a Microcephaly,
sparse, and thin
eyebrows
Hearing
impairment,
hirsutism
Cupped ear,
brachycephaly,
wide spaced
teeth, frontal
upsweep of hair
Delayed eruption of
permanent teeth,
high palate,
median cleft lip
and palate, widely
spaced teeth
Hypermetropia Nystagmus,
strabismus
Prominent median
palatal raphe
Brachycephaly, long
eyelashes, long
philtrum, low
anterior hairline,
microcephaly, up
slanted palpebral
fissures
Progressive
microcephaly,
synophrys,
widely spaced
teeth, bruxism
Narrow palpebral
fissures, mild
posterior rotation
of ears, high
palate, maligned
upper incisors
Chest/upper
limbs/hands:
n/a Short palm Broad thumb Bilateral single
transverse palmar
creases
n/a Bilateral postaxial
hand polydactyly
n/a n/a Clinodactyly of the
fifth finger
n/a Slender hands and
feet
Cardiac/other
organ
abnormality:
Anteriorly
placed
anus
n/a Cryptorchidism n/a Childhood-onset
truncal obesity
Obesity Hypothyroidism,
central
hypoventilation,
recurrent hand
flapping
ASD, PDA n/a Functional
respiratory
abnormality
Feeding difficulties
at 15 years,
breath-holding/
apnoeic episodes
Lower limbs Absent
patellar
reflexes
Short foot n/a n/a Short foot Right foot
Polydactyly
n/a n/a n/a Regressed
movement
Ataxic broad-based
gait
Seizures +Absence + + + Generalized
tonic-clonic
+ + Absence seizures
with atonic
element.
Tonic-clonic
seizures now
controlled.
n/a + + Generalized
tonic-clonic
seizures
+ Focal seizures
that become
generalized.
Can become
clustered.
+ Febrile, absence
and tonic-clonic
fits
Musculature Generalized
neonatal
hypotonia
n/a n/a n/a n/a Muscular hypotonia,
wheelchair due to
marked
ligamentous laxity
Central hypotonia,
fatigable
weakness
n/a n/a n/a n/a
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TABLE 6 (Continued)
Patient number 1 2 3 4 5 6 7 8 9 10 11
Decimal age at
review
0.67 years 11.32 years 16.24 years 10.95 year 12.58 years 2.77 years 2.58 years 4.09 years 15.85 years 11.75 years 9.99 years
Mat illness — — — — + — — — — + —
Gestation (weeks) 41 28 40 40 32 41 35 39 41 39 40
Admitted SCBU — n/a — — + — + 14 days — + 1 day — +7 days
Feeding problems + — — + + — + — — — + NGT
Height (percentile) 8.33 n/a 1 4 11 3 42 n/a 1 1 2
Age height
measured
11 months n/a 4 years 9 years 12 years 33 months 2 months n/a 4 years 8 years 6 years
Birth weight
(percentile)
3.2 99 3 1 92 90 33 10 5 10 62
Weight (percentile) 8.39 n/a 35 n/a 99 98 33.5 n/a 1 14 66
Age weight
measured
11 months n/a 4 years n/a 12 years 33 months 2 months n/a 4 years 8 years 6 years
OFC (percentile) 43 1 58 23 36 64 n/a 9 1 51 56
Age OFC measured 11 months 8 years 4 years 9 years 12 years birth n/a 17 months 4 years birth 6 years
Social smile n/a n/a n/a n/a n/a n/a n/a 6 weeks Unknown 9 weeks 5 months
Sat independently n/a 6 months 10 months 18 months n/a 9 months 2–2.5 years 12 months 6 months 12 months 2–2.5 years
Walked
independently
n/a 2–2.5 years 20 months 2.5–3 years 2.5–3 years 2–2.5 years Not yet
achieved
n/a 2–2.5 years Not yet achieved 12 months
First words n/a 13 months 18 months 2.5–3 years 5 years and
over
2.5–3 years (2-to
3-word
sentences aged
6)
2–2.5 years n/a 3–4 years Single word at
2 years,
regression to no
speech
Unknown
Prior pregnancy loss
in this
relationship
0 0 0 3+ 0 0 0 0 0 0 0
Consanguinity No No No No No No No No No No No
Is patient only
affected member
of family
Yes Yes Yes Yes Yes Yes Yes Yes No No Yes
Patient phenotype
reminiscent of
known syndrome
+SMA,
Prader–Willi,
myotonic
dystrophy
— — Angelman
syndrome
— — +Congenital
myasthenic
syndrome
— +, Cornelia
de Lange
— +, Angelman's, Fragile X,
Rett, X inactivation,
Smith Magenis
Cranial MRI Normal Abnormal n/a Normal Normal Abnormal Normal Abnormal Normal Abnormal Normal
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TABLE 7 Phenotypic data patients 12–21
Patient number 12 13 14 15 16 17 18 19 20 21
Decipher ID DDD-272038 DDD-270543 n/a n/a n/a n/a DDD-268082 n/a n/a n/a
Genotype c.1801C>T c.847_857del c.837_839del c.2167
+35_*415del
c.1089 G>A c.1641delA c.1681del c.454_466del c.706_707del c.712_715del
Protein change p.Arg601Ter p.
Phe283SerfsTer5
p.Glu279del 5.6kb deletion of
final 3 exons
(12-14)
p.Trp363* p.
Asp548llefs*5
p.
Gln561SerfsTer45
p.
Ala152ThrfsTer
pGlu236Thrfs*6 p.
Lys238AlafsTer100
Het/
homozygous
Het Het Het Het Het Het Het Het Het Het
Gender M F M M F F M F F
Developmental
delay
Present Severe, stereotypy Present Global, moderate
motor delay
Severe Severe Severe Severe Moderate to
severe
Unknown
Speech
impairment
Speech therapy 2 words- mum &
dad
Delayed Severe, single
words at
5 years
Absent speech No speech, only
one word
Regression can only
say “mummy”
Single words only Delayed Delayed
Degree of ID Cognitive
impairment
n/a Moderate, total
IQ 52
Moderate (special
unit in
mainstream
school, 1:1
help)
Severe Only word:
“Hi-ya”
Only word
“mummy”
Some basic
understanding
n/a n/a
Behavior Autistic Hand stereotypies;
bruxism
No Some aggressive
outbursts, no
sense of
danger
Bruxism Generally,
content but
capable of
tantrums
n/a Very stubborn,
autistic features
None diagnosed
but it can be
difficult.
Autism spectrum
disorder diagnosed
Stature n/a Short Slender build; -2
SD
Normal n/a Small n/a 0.4th centile n/a n/a
Craniofacial
dysmorphism
Abnormal facial
shape,
prominent,
heavy wide
arched
eyebrows,
triangular face,
flat
cheekbones
Strabismus,
drooling,
prominent nasal
bridge, wide
nasal bridge,
bruxism
Dolichocephaly,
prominent
forehead,
down slant,
slightly low
hanging
columella, thin
upper lip
Left-sided
plagiocephaly,
torticollis,
low-set ears,
prominent
forehead,
epicanthic
folds (L>R),
prominent
nasal tip,
sparse hair,
mild
hypermetropia
Dysplastic
earlobes, short
palpebral
fissures, broad
nasal bridge,
hypoplastic
alae nasi,
tented upper
lip, prominent
jaw,
microcephaly
Mild synophrys,
short nose
Coarse facial
features,
epicanthus, high
arched eyebrow,
long palpebral
fissure,
trigonocephaly,
widely spaced
teeth
Broad forehead,
small chin,
bilateral glue
ear, exotropia
Up slanting
palpebral
fissures, long
eyelashes,
thin upper lip
Frontal bossing,
prominent metopic
suture, flattened
nasal bridge, short
nose,
Chest/upper
limbs/hands
n/a Short 4th/5th
metacarpal,
tapered finger,
Long fingers n/a Small hands and
feet, tapering
fingers,
Short fingers Prominent fingertip
pads, broad
thumb
None Broad thumbs Bilateral postaxial
polydactyly
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TABLE 7 (Continued)
rhizomatic
shortening
bilateral single
palmar creases;
short fifth
fingers
Cardiac/other
organ
abnormality
n/a Episodic
hyperventilation
interspersed with
apnoea
associated with
cyanosis
n/a Trivial tricuspid
regurgitation
n/a n/a Kyphosis and
bilateral valgus
deformity
Lordosis,
constipation
Scoliosis, ASD Orchidopexy for
undescended testis
Lower limbs n/a Broad based gait Long toes Unsteady gait,
frequent falls
n/a Short toes n/a None Pes plaus, cold
feet
None
Seizures + (2 in lifetime) +, tonic clonic + Focal +(none since
4 years old)
+Febrile +Controlled +Tonic-clonic,
atypical absences,
later emergence
of tonic seizures,
and gelastic
seizures.
+Febrile seizures
present,
myoclonic
seizures,
atypical
absences,
non-convulsive
status.
Encephalopathy
suggested
+ + on Keppra
Musculature n/a n/a n/a Low muscle tone,
especially core
tone
n/a Reduced tone Joint laxity Reduced tone n/a Hypotonia, joint
laxity
Patient number 12 13 14 15 16 17 18 19 20 21
Decimal age at
review
16.68 years 17.63 years 13 years 5.7 years n/a n/a 13.9 years 8.5 years 23 years 5 years
Mat illness — — — — n/a — — + (pre-eclampsia causing
emergency cesarean)
— —
Gestation
(weeks)
40 37 40 39 Post-term 39 36 28+5 40+9 40+2
Admitted SCBU — No + 1 day — n/a + — +45 days + brief period —
Feeding
problems
— No — — n/a + + +Necrotizing enterocolitis — —
Height
(percentile)
1 3 13.6 30 n/a 119 cm
(percentile
n/a)
7 110 cm (percentile n/a) 141 cm
(percentile
n/a)
n/a
Age height
measured
15 years 3 years 13.5 4
(+2 months)
n/a 11 years,
5 months
8 years 8 years 23 years n/a
Birth weight
(percentile)
22 56 9 91 75–91st 50 8 9 2–9 2
(Continues)
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TABLE 7 (Continued)
Weight
(percentile)
5 18 kg
(percentile
n/a)
32.7 kg
(percentile
n/a)
82 n/a 29 kg
(percentile
n/a)
95 30 kg (percentile n/a) 46 n/a
Age weight
measured
(years)
15 years 7.5 years 13.5 years 5 (+3 months) n/a 11 years
5 months
8 years 8 years + 6 months 23 y n/a
OFC
(percentile)
n/a 10 57.2 cm
(percentile
n/a)
99 n/a 49.5 cm
(percentile
n/a)
26 2 51 3.6
Age OFC
measured
(years)
n/a 3 years 13.5 years 5
(+ 3 months)
n/a 11 years
5 months
8 years Birth 23 years Birth
Social smile Unknown Unknown Unknown unknown n/a n/a 8 weeks Unknown Unknown Unknown
Sat
Independently
Unknown 15 months Unknown 12 months n/a 3 years 14 months Unknown Unknown 16 months
Walked
independently
Unknown 2.5–3 years 2 years 2 years Non-mobile 5–8 years 2–2.5 years 2 years 2 years 3 years
First words Unknown 3 years 2 years 2.5 years n/a None not yet
achieved
3.5 years 2 years 14 months
Prior pregnancy
loss in this
relationship
0 0 0 0 n/a 2 0 unknown unknown 3
Is there
consanguinity
No No No No n/a No No No No No
Is patient only
affected
member of
family
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Patient
phenotype
reminiscent
of known
syndrome
+,
Cornelia-de
Lange
+, Rett Pitt
Hopkin
— +, Mild
Angelman
+ Rett — — + Rett +, Cornelia de
Lange
—
Cranial MRI n/a n/a Normal Normal Normal Normal Abnormal Abnormal Normal Normal
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this gene, we are unable to back this by clinical evidence. The majority of
identified missense and in-frame deletions published so far are outside
of the p.521-p.640 region upstream of the RGG domain, that is, p.
(Glu140Lys) (Yates et al., 2017); p.(Arg324Gly), p.(Thr582_Gln589del), p.
(Ser378Pro) (Bramswig et al., 2017); and the p.(Glu279del) region in our
study. Therefore, without functional studies, we cannot propose the
presence of a mutation hotspot within the gene. On the other hand, the
HNRNPU gene pLI score is 1 (pLI ≥0.9 are extremely LoF intolerant),
suggesting haploinsufficiency as the main mechanism of pathogenicity in
this gene. This is backed with genotypic data presented in our study and
previously published work.
It is worth noting that although rare, there are handful numbers
of apparently healthy individuals reported in gnomAD with truncating
variants predicted to result in NMD and haploinsufficiency: gnomAD
v2.1.1 accessed 23rd March 2020; Genome build GRCh37/hg19;
Ensembl gene ID ENSG00000153187.12; Canonical transcript ID
ENST00000283179.9 (https://gnomad.broadinstitute.org). This is not
unusual as not all individuals in gnomAD are completely disease-free
and detailed phenotypic information is not always available. There-
fore, our work is vital in avoiding misclassification of these variants
based on their presence at low frequency in control population data.
One of the main ACMG criteria used to achieve pathogenic classifica-
tion was PS2 (de novo), highlighting the importance of testing parents
if appropriate in newly diagnosed cases to check if the variant has
risen de novo in the proband.
5 | CONCLUSIONS
In summary, we present here the largest cohort of HNRNPU-related
syndrome to date comprising ID, behavioral disorders, epilepsy, and
craniofacial dysmorphism. This follows on from the previous paper
from our group (Yates et al., 2017). The data presented here
broaden the phenotypic spectrum establishing similar patterns of
seizure profiling and development to previously published
literature.
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